Michael Salinger was a moderator at this conference on “Fintechs: How to Ensure a Level Playing Field for All?”
For more information on this event, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
